SCHEMBL2995689

SCHEMBL2995689

CN1CCCN(c2ccc(N(Cc3ccccc3)Cc3ccccc3)c(F)c2)C1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 1/20 0.38
DRD2 P14416 5/20 0.37
DRD1 P21728 1/20 0.37
RORC P51449 2/20 0.36
LMNA P02545 2/20 0.35
DRD3 P35462 4/20 0.34
KCNH2 Q12809 2/20 0.34
MAPT P10636 1/20 0.34
PER2 O15055 1/20 0.33
PARP1 P09874 1/20 0.33
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33
HTR2B P41595 1/20 0.33
F2 P00734 1/20 0.32
F10 P00742 1/20 0.32
PKM P14618 1/20 0.32
NPC1 O15118 1/20 0.32
ALDH1A1 P00352 1/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2993937 0.81 HCRTR1 (0.44) LMNAPARP1F10NPC1ALDH1A1
SCHEMBL2994194 0.78 PER2 (0.36) HTR6DRD2DRD1RORCDRD3
SCHEMBL27806750 0.74 DRD2 (0.39) HTR6DRD2DRD1RORCLMNA
SCHEMBL2999231 0.73 DRD3 (0.38) DRD2DRD3KCNH2MAPTPER2
SCHEMBL2984910 0.73 DRD2 (0.43) DRD2DRD1RORCLMNAPER2
SCHEMBL12930942 0.72 MAPT (0.39) LMNAKCNH2MAPTF10NPC1
SCHEMBL6362778 0.71 MEN1 (0.61) DRD2DRD3PER2HTR2AHTR2C
SCHEMBL3000578 0.70 SMYD2 (0.34) DRD2DRD1RORCF10SMN1; SMN2
SCHEMBL27806587 0.70 DRD2 (0.35) HTR6DRD2DRD1RORC
SCHEMBL8232824 0.69 F10 (0.44) DRD2DRD3KCNH2F2F10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100184767-A1 SUBSTITUTED OXAZOLIDINONES AND USE THEREOF ROHRIG SUSANNE 2010-07-22 US disclosed
US-20100184767-A1 SUBSTITUTED OXAZOLIDINONES AND USE THEREOF ROHRIG SUSANNE 2010-07-22 US disclosed
US-20100184767-A1 SUBSTITUTED OXAZOLIDINONES AND USE THEREOF ROHRIG SUSANNE 2010-07-22 US disclosed
WO-2008155034-A1 SUBSTITUTED OXAZOLIDINONES AND THE USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-12-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100184767-A1 SUBSTITUTED OXAZOLIDINONES AND USE THEREOF XDH, OXA1L, PPOX HTR6 3491/4885DRD2 2776/4885DRD1 2678/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.